Livongo Health has announced it has secured $20 million in series B funding.

Livongo, with offices in Chicago and Mountain View, Calif., is a developer of chronic disease management tools, including a cloud-enabled glucose meter.

Participating investors included Kleiner Perkins Caufield & Byers, DFJ and previous investor General Catalyst.

Livongo indicated the funding will go toward further developing the company’s chronic disease management ecosystem and accelerating the adoption of the company’s digital diabetes management program, Livongo for Diabetes, among self-insured employers, healthcare providers and payers.